Mary Mosher

Array ( [id] => 7216521 [patent_doc_number] => 20040071709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Corona-virus-like particles comprising functionally deleted genomes' [patent_app_type] => new [patent_app_number] => 10/414256 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14435 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20040071709.pdf [firstpage_image] =>[orig_patent_app_number] => 10414256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397565 [patent_doc_number] => 20040038922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Vaccine composition' [patent_app_type] => new [patent_app_number] => 10/398361 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4198 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038922.pdf [firstpage_image] =>[orig_patent_app_number] => 10398361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6830604 [patent_doc_number] => 20030181662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Human procalcitonin and the preparation and use thereof' [patent_app_type] => new [patent_app_number] => 10/394058 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12461 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181662.pdf [firstpage_image] =>[orig_patent_app_number] => 10394058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678190 [patent_doc_number] => 20030228330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods' [patent_app_type] => new [patent_app_number] => 10/388234 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7740 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228330.pdf [firstpage_image] =>[orig_patent_app_number] => 10388234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7384150 [patent_doc_number] => 20040180094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Activation agents on the surface of encapsulation vesicles' [patent_app_type] => new [patent_app_number] => 10/387301 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15247 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180094.pdf [firstpage_image] =>[orig_patent_app_number] => 10387301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014303 [patent_doc_number] => 06893643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-17 [patent_title] => 'Recombinant yellow fever virus and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/383956 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 12466 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/893/06893643.pdf [firstpage_image] =>[orig_patent_app_number] => 10383956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 951144 [patent_doc_number] => 06960345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-01 [patent_title] => 'Oral vaccinia formulation' [patent_app_type] => utility [patent_app_number] => 10/379572 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8965 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/960/06960345.pdf [firstpage_image] =>[orig_patent_app_number] => 10379572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664031 [patent_doc_number] => 20030203357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Mixed cell diagnostic systems' [patent_app_type] => new [patent_app_number] => 10/382713 [patent_app_country] => US [patent_app_date] => 2003-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16699 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203357.pdf [firstpage_image] =>[orig_patent_app_number] => 10382713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796417 [patent_doc_number] => 20030175291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Multiple and multivalent DNA vaccines in ovo' [patent_app_type] => new [patent_app_number] => 10/377718 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6365 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175291.pdf [firstpage_image] =>[orig_patent_app_number] => 10377718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7390142 [patent_doc_number] => 20040037848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Recombinant vaccine against West Nile Virus' [patent_app_type] => new [patent_app_number] => 10/374953 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26117 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20040037848.pdf [firstpage_image] =>[orig_patent_app_number] => 10374953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769855 [patent_doc_number] => 20030215795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Highly infectious rubella virus DNA constructs and methods of production' [patent_app_type] => new [patent_app_number] => 10/373650 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13530 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215795.pdf [firstpage_image] =>[orig_patent_app_number] => 10373650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6705849 [patent_doc_number] => 20030152583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Soluble herpesvirus glycoprotein complex vaccine' [patent_app_type] => new [patent_app_number] => 10/370200 [patent_app_country] => US [patent_app_date] => 2003-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18670 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20030152583.pdf [firstpage_image] =>[orig_patent_app_number] => 10370200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359536 [patent_doc_number] => 07485415 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Sequence analysis of the tetravalent rotavirus vaccine' [patent_app_type] => utility [patent_app_number] => 10/505818 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13700 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485415.pdf [firstpage_image] =>[orig_patent_app_number] => 10505818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6842572 [patent_doc_number] => 20030147919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Parvovirus capsids' [patent_app_type] => new [patent_app_number] => 10/366810 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 6794 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20030147919.pdf [firstpage_image] =>[orig_patent_app_number] => 10366810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4467963 [patent_doc_number] => 07943144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Herpes simplex virus complex' [patent_app_type] => utility [patent_app_number] => 10/504460 [patent_app_country] => US [patent_app_date] => 2003-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5087 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943144.pdf [firstpage_image] =>[orig_patent_app_number] => 10504460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 474958 [patent_doc_number] => 07226774 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-05 [patent_title] => 'Signal for packaging of influenza virus vectors' [patent_app_type] => utility [patent_app_number] => 10/366630 [patent_app_country] => US [patent_app_date] => 2003-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 42 [patent_no_of_words] => 24523 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/226/07226774.pdf [firstpage_image] =>[orig_patent_app_number] => 10366630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111024 [patent_doc_number] => 20050208479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Human antibodies for use as a therapeutic agent against vaccinia or small pox' [patent_app_type] => utility [patent_app_number] => 10/504386 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1758 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208479.pdf [firstpage_image] =>[orig_patent_app_number] => 10504386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141326 [patent_doc_number] => 20070003542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Methods for treating diseases or conditions with peptide constructs' [patent_app_type] => utility [patent_app_number] => 10/502328 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11705 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003542.pdf [firstpage_image] =>[orig_patent_app_number] => 10502328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7429942 [patent_doc_number] => 20040001864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Vaccine against foot-and-mouth disease' [patent_app_type] => new [patent_app_number] => 10/327481 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13903 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001864.pdf [firstpage_image] =>[orig_patent_app_number] => 10327481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333348 [patent_doc_number] => 20040131639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'NOVEL RECOMBINANT TRYPTOPHAN MUTANTS OF INFLUENZA' [patent_app_type] => new [patent_app_number] => 10/328114 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11805 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131639.pdf [firstpage_image] =>[orig_patent_app_number] => 10328114 [rel_patent_id] =>[rel_patent_doc_number] =>)